Location: Home
  • search
  • go
  • Relate News
  • 3/23/2021Citrine Granted Clinical Trial Waiver for Narcolepsy Drug Wakix and ...
  • 3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum
  • 3/18/2021Ping An Good Doctor: Cross-Sectional Survey
  • 3/17/2021Pfizer To Be Granted Priority Review for Its NDA of Abrocitinib
  • 3/16/2021Snapshot of Biological Product Registration and Launch in China Last Y...
  • 3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept
  • 3/16/2021China Approves Another COVID-19 Vaccine for Emergency Use
  • 3/12/2021NHC Issues the Pediatric Vaccine Inoculation Procedures and Notes of t...
  • 3/9/2021Sinopharm Faces Battle to Turn Covid Vaccine into a Global Success
  • 3/8/2021Eli Lilly Launches Verzenio (Abemaciclib) in China
  • 3/4/2021SciClone Launches IPO on the Main Board of the Hong Kong Stock Exchang...
  • 3/3/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
  • 3/2/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
  • 3/1/2021NMPA Solicits Comments on the Draft Measures for Control of Vaccine Pr...
  • 2/25/2021China Approves Two More Domestic COVID-19 Vaccines
  • 2/8/2021Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...
  • 2/8/2021IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...
  • 2/8/2021Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
  • 2/2/2021AZ's Chinese Partner Kangtai Bio Expects to Make 400M COVID-19 Vaccine...
  • 2/1/2021GSK Ends COVID-19 Vaccine Partnership with Clover
  • 2/1/2021Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of...
  • 2/1/2021Legend Biotech Announces BCMA CAR-T Cilta-cel Accepted for Accelerated...
  • 1/28/2021Citrine Med and Diurnal Announce Strategic Partnership for Pediatric ...
  • 1/28/2021Bio-Thera Files Biologics License Application Avastin Biosimilar with ...
  • 1/22/2021Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...
  • 1/22/2021Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China
  • 1/21/2021Sinovac Increases Vaccine Production to Ensure Global Supply
  • 1/21/2021Chinese Civil Code Introduces Punitive Damages Against IP Infringement
  • 1/19/2021Innovent Announces an Out-license Deal with PT Etana to Launch Bevaciz...
  • 1/13/2021Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum  in C...
  • Page:11/68 Total number of articles:2025: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group